Maxlinear (MXL) EBIT (2010 - 2026)

Maxlinear (MXL) has reported EBIT for 17 consecutive years, with -$4.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBIT rose 83.0% year-over-year to -$4.2 million in Q2 2026; TTM through Jun 2026 was -$77.6 million, a 56.57% increase from a year earlier, with the FY2025 full-year figure at -$126.9 million, up 43.19% from the prior year.
• EBIT was -$4.2 million for Q2 2026 at Maxlinear, up from -$17.2 million in the prior quarter.
• Over five years, EBIT peaked at $51.9 million in Q3 2022 and troughed at -$74.6 million in Q1 2024.
• A 5-year average of -$12.8 million and a median of -$17.5 million in 2023 frame the typical range for EBIT.
• Across the five-year window, EBIT soared 1669.83% in 2022 and tumbled 587.55% in 2024, its largest moves.
• Over 5 years, EBIT stood at $41.2 million in 2022, then tumbled by 201.41% to -$41.7 million in 2023, then advanced by 1.37% to -$41.2 million in 2024, then jumped by 63.83% to -$14.9 million in 2025, then jumped by 71.9% to -$4.2 million in 2026.
• The last three EBIT figures came in at -$4.2 million (Q2 2026), -$17.2 million (Q1 2026), and -$14.9 million (Q4 2025), per Business Quant data.